RAPIDZ
DEAD

Serial Number

97146181

Owner

Access Medical Systems

Attorney

Viola T. Kung

Filing Date

Nov 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RAPIDZ Trademark

Serial Number: 97146181

RAPIDZ is a trademark filed by Access Medical Systems on November 29, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Access Medical Systems (7 trademarks)

1455 Adams Dr 1322
Menlo Park, CA 94025

Entity Type: 03

Trademark Details

Filing Date

November 29, 2021

Registration Date

Not Registered

Published for Opposition

October 3, 2023

Goods & Services

Instruments for analysis of bodily fluids for scientific or research purposes; scientific instruments for determining the presence or concentration of biomolecules in bodily fluids; instruments for using lateral flow assays, lateral flow immunoassays, and lateral flow immunochromatographic assays for scientific or research purposes; devices other than for medical or veterinary purposes, namely, cartridges for receiving lateral flow test strips to be analyzed for scientific or research purposes; assay readers other than for medical or veterinary use, namely, lateral flow readers; assaying instruments, namely, laboratory instruments in the nature of assay readers for scientific or research purposes; bioassay devices, namely, bioassay analyzers for measuring, testing, and analyzing samples of bodily fluids and parts therefor, for scientific or research purposes; devices for confirming the presence or absence of an analyte, other than for medical purposes; diagnostic devices that employ immunoassay technology to detect the presence of analytes in bodily fluids for scientific or research purposes; diagnostic equipment, namely, lateral flow readers, lateral flow test strips, and lateral flow preparation kits for scientific or research purposes comprised of droppers for laboratory use, scientific research specimen collection devices comprised of swabs and capillaries for the collection of bodily fluids being blood and urine, and buffer

Diagnostic kits comprised of medical diagnostic reagents and assays for analysis of bodily fluids for use in disease detection, namely, infectious diseases, cancer, cardiovascular diseases, fertility conditions, pulmonary diseases, brain diseases, liver diseases, bone diseases, diabetes, autoimmune diseases, thyroid diseases, and kidney diseases; diagnostic kits, namely, test strips and appropriate reagents and buffers for determining the presence or concentration of biomolecules in bodily fluids for use in disease detection, namely, infectious diseases, cancer, cardiovascular diseases, fertility conditions, pulmonary diseases, brain diseases, liver diseases, bone diseases, diabetes, autoimmune diseases, thyroid diseases, and kidney diseases; medical diagnostic test strips for analysis of bodily fluids; medical diagnostic test strips for use in detecting the presence of analytes; medical diagnostic test strips for use in detecting indicators of diseases, such indicators being enzymes, antigens, antibodies, and nucleic acids; medical diagnostic test strips for lateral flow devices; medical diagnostic test strips for lateral flow assays, lateral flow immunoassays, and lateral flow immunochromatographic assays; lateral flow assays, lateral flow immunoassays, and lateral flow immunochromatographic assays for detecting infectious diseases, cancer, cardiovascular diseases, fertility conditions, pulmonary diseases, brain diseases, liver diseases, bone diseases, diabetes, autoimmune diseases, thyroid diseases, and kidney diseases; preparations for medical or veterinary purposes, namely, reagents and buffers for diagnostics preparations for medical or veterinary purposes, namely, reagents and buffers for use in detecting antigens or antibodies in liquid samples; diagnostic reagents for medical or veterinary use; buffer solutions for medical or veterinary use; diagnostic preparations for medical and veterinary use; pharmaceutical preparations for detecting infectious diseases, cancer, cardiovascular diseases, fertility conditions, pulmonary diseases, brain diseases, liver diseases, bone diseases, diabetes, autoimmune diseases, thyroid diseases, and kidney diseases or monitoring therapeutic drug effectiveness and reactivity; diagnostic substances for medical or veterinary use; lateral flow test strips for use in the field of point-of-care, at home testing, and professional laboratories for analysis of bodily fluids, namely, blood, urine, saliva, and sweat; lateral flow preparation kits comprised of medical diagnostic test strips for use in the field of point-of-care, at home testing, and professional laboratories for analysis of bodily fluids, namely, blood, urine, saliva, and sweat, medical diagnostic reagents, vials for medical specimens and reagents, swabs for medical use, and medical specimen collecting tools

Preparations for diagnostic purposes other than for medical or veterinary purposes; diagnostic substances other than for medical or veterinary use; diagnostic substances for use in lateral flow assays, lateral flow immunoassays, and lateral flow immunochromatographic assays, other than for medical or veterinary use; lateral flow preparation kits comprised of chemically treated non-medical test strips for detecting disease other than for medical or veterinary use, reagents for scientific and research use, sample and reagent vials, and specimen collection tools

Medical services, namely, diagnostic testing for analytes in bodily fluids; medical diagnostic testing relating to human health; medical services related to immunodiagnostic testing; medical testing services for diagnostic or treatment purposes; medical testing services relating to the diagnosis or treatment of disease; medical testing services, namely, conducting of lateral flow assays, lateral flow immunoassays, and lateral flow immunochromatographic assays for diagnostic or treatment purposes

Instruments for analysis of bodily fluids for medical or veterinary purposes; medical instruments for determining the presence or concentration of biomolecules in bodily fluids; instruments for using lateral flow assays, lateral flow immunoassays, and lateral flow immunochromatographic assays for medical or veterinary purposes; devices for medical or veterinary purposes, namely, cartridges for receiving lateral flow test strips to be analyzed for diagnostic purposes; assay readers for medical or veterinary use, namely, lateral flow readers; devices for carrying out diagnostic tests for medical purposes; devices for confirming the presence or absence of an analyte for medical purposes; medical diagnostic devices that employ immunoassay technology to detect the presence of analytes in bodily fluids; medical diagnostic equipment, namely, lateral flow readers

Scientific services, namely, detection and analysis of analytes in bodily fluids; scientific and clinical research in the field of biomolecules; scientific and clinical research in the fields of lateral flow readers, lateral flow test strips, and lateral flow preparation kits; scientific and clinical research in the fields of lateral flow assays, lateral flow immunoassays, and lateral flow immunochromatographic assays; biological research; biochemical research; research and development services in the field of reagents; research and development services in the fields of lateral flow readers, lateral flow test strips, and lateral flow preparation kits; research and development services in the fields of lateral flow assays, lateral flow immunoassays, and lateral flow immunochromatographic assays; research and development services in the field of diagnostic instruments

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 30, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 30, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 23, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 22, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 22, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 22, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 21, 2024 EX1G
SOU EXTENSION 1 FILED
May 21, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 21, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 28, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 29, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 29, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 29, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 29, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 25, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 18, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 2, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 9, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2021 NWOS
NEW APPLICATION ENTERED
Dec 2, 2021 NWAP